Effects of a 1,3-diacylglycerol oil-enriched diet on postprandial lipemia in people with insulin resistance

Journal of Lipid Research

Volumn 49, Issue 3, 2008, Pages 670-678

  Reyes, Gissette ^a   Yasunaga, Koichi ^a   Rothenstein, Eileen ^a   Karmally, Wahida ^a   Ramakrishnan, Rajasekhar ^a   Holleran, Stephen ^a   Ginsberg, Henry N ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

Hypertriglyceridemia; Lipoproteins; Triglycerides

Indexed keywords

1,3 DIACYLGLYCEROL; DIACYLGLYCEROL; GLUCOSE; INSULIN; LIPID; LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; ADOLESCENT; AGED; DIET THERAPY; HYPERTRIGLYCERIDEMIA; MIDDLE AGED; POSTPRANDIAL STATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CROSS-OVER STUDIES; DIET THERAPY; DIGLYCERIDES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; TREATMENT OUTCOME;

EID: 42949110842     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P700019-JLR200     Document Type: Article

References (52)

1. Geiss, L. S., M. A. Liping Pan, B. Cadwell, E. W. Gregg, S. M. Benjamin, and M. M. Engelgau. 2006. Changes in incidence of diabetes in US adults, 1997-2003. Am. J. Prev. Med. 30: 371-377.
2. Keeny, S. J., R. E. Aubert, and L. S. Geiss. 1995. Prevalence and Incidence of Insulin Dependent Diabetes in America. National Institutes of Health, Bethesda, MD.
3. Geiss, L. S., W. H. Herman, and P. J. Smith. 1995. Mortality in non-insulin-dependent diabetes. In Diabetes in America. National Institutes of Health, Bethesda, MD. 233-257.
4. Reaven, G. M. 2005. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med. 47: 201-210.
5. Reaven, G. M. 2005. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu. Rev. Nutr. 25: 391-406.
6. Reaven, G. M., and Y-D. Chen. 1988. Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab. Rev. 4: 639-652.
7. Reaven, G. M. 1988. Role of insulin resistance in human disease. Diabetes. 37: 1595-1607.
8. Adeli, K., C. Taghibiglou, S. C. Van Iderstine, and G. F. Lewis. 2001. Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. Trends Cardiovasc. Med. 11: 170-176.
9. Chahil, T. J., and G. N. Ginsberg. 2006. Diabetic dyslipidemia. Endocrinol. Metab. Clin. North Am. 35: 491-510.
10. Ginsberg, H. N., and D. R. Illingworth. 2001. Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes. Am. J. Cardiol. 88: 9H-15H.
11. Ginsberg, H. N., J. Jones, W. S. Blaner, A. Thomas, W. Karmally, L. Fields, D. Blood, and M. D. Begg. 1995. Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women. Arterioscler. Thromb. Vasc. Biol. 15: 1829-1838.
12. Sharret, A. R., G. Heiss, L. E. Chambless, E. Boerwinkle, S. A. Coady, A. R. Folsom, and W. Patsch. 2001. Metabolic and lifestyle determinants of postprandial lipemia differ from those of fasting triglycerides. Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler. Thromb. Vasc. Biol. 21: 275-281.
13. Bansal, S., J. E. Buring, N. Rifai, S. Mora, F. M. Sacks, and P. M. Ridker. 2007. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. J. Am. Med. Assoc. 298: 309-316.
14. Nordestgaard, B. G., M. Benn, P. Schnohr, and A. Tybjaerg-Hansen. 2007. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. J. Am. Med. Assoc. 298: 299-308.
15. Karpe, F. 1997. Mechanisms of postprandial hyperlipedemia - remnants and coronary artery disease. Diabet. Med. 14 (Suppl. 3): 60-66.
16. Karpe, F. 1999. Postprandial metabolism and atherosclerosis. J. Intern. Med. 246: 341-355.
17. Ginsberg, H. N. 1998. Lipoprotein physiology. Endocrinol. Metab. Clin. North Am. 27: 503-519.
18. Hanyu, O., T. Milda, K. Obayashi, T. Ikarashi, S. Soda, S. Kaneko, S. Hirayama, K. Suzuk, Y. Nakamura, K. Yamatani, et al. 2004. Lipoprotein lipase (LPL) mass in preheparin serum reflects insulin sensitivity. Atherosclerosis. 174: 385-390.
19. Cohn, J. S., M. Tremblay, R. Batal, H. Jacques, C. Rodirguez, G. Steiner, O. Mamer, and J. Davignon. 2004. Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia. Atherosclerosis. 177: 137-145.
20. Ebara, T., K. Conde, Y. Kako, Y. Liu, Y. Xu, R. Ramakrishnan, I. J. Goldberg, and N. S. Shachter. 2000. Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice. J. Clin. Invest. 105: 1807-1818.
21. Haidari, M., N. Leung, F. Mahbub, K. D. Uffelman, R. Kohen-Avramoglu, G. F. Lewis, and K. Adeli. 2002. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. J. Biol. Chem. 277: 31646-31655.
22. Duez, H., B. Lamarche, K. D. Uffelman, R. Valero, J. S. Cohn, and G. F. Lewis. 2006. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B48 containing lipoproteins in humans. Arterioscler. Thromb. Vasc. Biol. 26: 1357-1363.
23. Rudkowska, I., C. E. Roynette, I. Demonty, C. A. Vanstone, S. Jew, and P. J. H. Jones. 2005. Diacylglycerol: efficacy and mechanism of action of an anti-obesity agent. Obes. Res. 13: 1864-1876.
24. Kondo, H., T. Hase, T. Murase, and I. Tokimitsu. 2003. Digestion and assimilation features of dietary DAG in the rat small intestine. Lipids. 38: 25-30.
25. Murase, T., M. Aoki, T. Wakisaka, T. Hase, and I. Tokimitsu. 2002. Anti-obesity effect of dietary diacylglycerol in C57BL/6J mice: dietary diacylglycerol stimulates intestinal lipid metabolism. J. Lipid Res. 43: 1312-1319.
26. Murase, T., T. Mizuno, T. Omachi, K. Onizawa, Y. Komine, H. Kondo, T. Hase, and I. Tokimitsu. 2001. Dietary diacylglycerol suppresses high fat and high sucrose diet-induced body fat accumulation in C57BL/6J mice. J. Lipid Res. 42: 372-378.
27. Murata, M., T. Ide, and K. Hara. 1997. Reciprocal responses to dietary diacylglycerol of hepatic enzymes of fatty acid synthesis and oxidation in the rat. Br. J. Nutr. 77: 107-121.
28. Mori, Y., H. Nakagiri, H. Kondo, T. Murase, I. Tokimitsu, and N. Tajima. 2005. Dietary diacylglycerol reduces postprandial hyperlipidemia and ameliorates glucose intolerance in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. Nutrition. 21: 933-939.
29. Bauer, J. E., D. Nagaoka, B. Porterpan, K. Bigley, T. Umeda, and K. Otsuji. 2006. Postprandial lipolytic activities, lipids, and carbohydrate metabolism are altered in dogs fed diacylglycerol meals containing high and low glycemic index starches. J. Nutr. 136 (Suppl. 7): 1955S-1957S.
30. Umeda, T., J. E. Bauer, and K. Otsuji. 2006. Weight loss effect of dietary diacylglycerol in obese dogs. J. Anim. Physiol. Anim. Nutr. (Berl.). 90: 208-215.
31. Taguchi, H., H. Watanabe, K. Onizawa, T. Nagao, N. Gotoh, T. Yasukawa, R. Tsushimi, H. Shimasaki, and H. Itakura. 2000. Double-blind controlled study on the effects of dietary diacylglycerol on postprandial serum and chylomicron triacylglycerol responses in healthy humans. J. Am. Coll. Nutr. 19: 789-796.
32. Tada, N., H. Watanabe, N. Matsuo, I. Tokimitsu, and M. Okazaki. 2002. Dynamics of postprandial remnant-like lipoprotein particles in serum after loading of diacylglycerols. Clin. Chim. Acta. 311: 109-117.
33. Tomonobu, K., T. Hase, and I. Tokimitsu. 2006. Dietary diacylglycerol in a typical meal suppresses postprandial increases in serum lipid levels compared with dietary triacylglycerol. Nutrition. 22: 128-135.
34. Tada, N., K. Shoji, M. Takeshita, H. Watanabe, H. Yoshida, T. Hase, N. Matsuo, and I. Tokimitsu. 2005. Effects of diacylglycerol ingestion on postprandial hyperlipedemia in diabetes. Clin. Chim. Acta. 3536: 87-94.
35. Takase, H., K. Shoji, T. Hase, and I. Tokimitsu. 2005. Effects of diacylglycerol on postprandial lipid metabolism in non-diabetic subjects with and without insulin resistance. Atherosclerosis. 180: 197-204.
36. Saito, S., M. Takeshita, K. Tomonobu, N. Kudo, D. Shiiba, T. Hase, I. Tokimitsu, and T. Yasukawa. 2006. Dose-dependent cholesterol-lowering effect of a mayonnaise-type product with a main component of diacylglycerol-containing plant sterol esters. Nutrition. 22: 174-178.
37. Maki, K. C., M. H. Davidson, R. Tsushimi, N. Matsuo, I. Tokimitsu, D. M. Umporowicz, M. R. Dicklin, G. S. Foster, K. A. Ingram, B. D. Anderson, et al. 2002. Consumption of diacylglycerol oil as part of a reduced-energy diet enhances loss of body weight and fat in comparison with consumption of a triacylglycerol control oil. Am. J. Clin. Nutr. 76: 1230-1236.
38. Yasunaga, K., W. H. Glinsmann, Y. Seo, Y. Katsuragi, S. Kobayashi, B. Flickinger, E. Kennepohl, T. Yasukawa, and J. F. Borzelleca. 2004. Safety aspects regarding the consumption of high-dose dietary diacylglycerol oil in men and women in a double-blind controlled trial in comparison with consumption of a triacylglycerol control oil. Food Chem. Toxicol. 42: 1419-1429.
39. Watanabe, H., K. Onizawa, S. Naito, H. Taguchi, N. Goto, T. Nagao, N. Matsuo, I. Tokimitsu, T. Yasukawa, R. Tsushima, et al. 2001. Fat-soluble vitamin status is not affected by diacylglycerol consumption. Ann. Nutr. Metab. 45: 259-264.
40. Watanabe, T., M. Shimizu, M. Sugiura, M. Sato, J. Kohori, N. Yamada, and K. Nakanishi. 2003. Optimization of reaction conditions for the production of DAG using immobilized 1,3-regiospecific lipase lipozyme RM IM. J. Am. Oil Chem. Soc. 80: 1201-1207.
41. Goldberg, I. J., C. A. Scheraldi, L. K. Yacoub, U. Saxena, and C. L. Bisgaier. 1990. Lipoprotein apoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J. Biol. Chem. 265: 4266-4272.
42. Nagashima, K., C. Lopez, D. Donovan, C. Ngai, N. Fontanez, A. Bensadoun, J. Fruchart-Najib, S. Holleran, J. S. Cohn, R. Ramakrishnan, et al. 2005. Effects of the PPAR agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus. J. Clin. Invest. 115: 1323-1332.
43. Adult Treatment Panel III. 2001. Executive summary of the third report of the NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J. Am. Med. Assoc. 285: 2486-2497.
44. Murata, M., K. Hara, and T. Ide. 1994. Alteration by diacylglycerol of the transport of fatty acid composition of lymph chylomicrons in rats. Biosci. Biotechnol. Biochem. 58: 1416-1419.
45. Yanagita, T., I. Ikeda, Y. M. Wang, and H. Nakagiri. 2004. Comparison of the lymphatic transport of radiolabeled 1,3-dioleoylglycerol and trioylglycerol in rats. Lipids. 39: 827-832.
46. Yasunaga, K., S. Saito, Y. L. Zhang, A. Hernandez-Ono, and H. N. Ginsberg. 2007. Effects of triacylglycerol and diacylglycerol oils on blood clearance, tissue uptake, and hepatic apolipoprotein B secretion in mice. J. Lipid Res. 48: 1108-1121.
47. Yamamoto, K., H. Asakawa, K. Tokunaga, S. Meguro, H. Watanabe, I. Tokimitsu, and N. Yagi. 2005. Effects of diacylglycerol administration on serum triacylglycerol in a patient homozygous for complete lipoprotein lipase deletion. Metabolism. 54: 67-71.
48. Syvanne, M., P. J. Talmud, S. E. Humphries, R. M. Fisher, M. Rosseneu, H. Hilden, and M. R. Taskinen. 1997. Determinants of postprandial lipemia in men with coronary artery disease and low levels of HDL cholesterol. J. Lipid Res. 38: 1463-1472.
49. Yamamoto, K., M. Takeshita, I. Tokimitsu, H. Watanabe, T. Mizuno, H. Asakawa, K. Tokunaga, T. Tatsumi, M. Okazaki, and N. Yagi. 2006. Diacylglycerol oil ingestion in type 2 diabetic patients with hypertriglyceridemia. Nutrition. 22: 23-29.
50. Yoneyama, S., K. Miura, S. Sasaki, K. Yoshita, Y. Morikawa, M. Ishizaki, T. Kido, Y. Naruse, and H. Nakagawa. 2007. Dietary intake of fatty acids and serum C-reactive protein in Japanese. J. Epidemiol. 17: 86-92.
51. Yamamoto, K., H. Asakawa, K. Tokunaga, H. Watanabe, N. Matsuo, I. Tokimitsu, and N. Yagi. 2001. Long-term ingestion of dietary diacylglycerol lowers serum triacylglycerol in type II diabetic patients with hypertriglyceredemia. J. Nutr. 131: 3204-3207.
52. Miller, M., A. Seidler, A. Moalemi, and T. A. Pearson. 1998. Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study. J. Am. Coll. Cardiol. 31: 1252-1257.